Elevance Health Q2 2026 Results Beat Expectations, Raises EPS Guidance
Elevance Health reported second quarter 2026 operating revenue of $49.8 billion and adjusted diluted EPS of $7.45, beating expectations. The company raised its fiscal 2026 adjusted diluted EPS guidance to at least $27.00 and operating cash flow guidance to at least $6.0 billion.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day